chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: feeling unwell; sick to stomach; vomiting; chest pains; hard to breath; chills/freezing; weak; 104 fever; sore arm; sore muscles; This is a spontaneous report received from a contactable consumer (patient's mother). A 18-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 22Mar2021 14:00 (02:00 PM) (Lot Number: EP6955) at the age of 18 years old as single dose for covid-19 immunisation. Medical history included Known allergies Morphine and sulfa antibiotics; Marphans syndrome, autistic, severe scoliosis & kyphosis. The patient's concomitant medications received within 2 weeks of vaccination included too many to put down here not enuf room. Facility where the most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The mother took care of the patient due to his sever disability iam filling this out for his as he was unable so he received shot (pending clarification), registered with v-safe, 22Mar2021 2pm. Fine, health check next 23Mar2021 day sore arm, kinda sore muscles, 24Mar2021, sore arm still sore muscles, 25Mar2021 13:00 (1pm), feeling unwell, sick to stomach started vomiting, chest pains, hard to breath, called 911 EMS advised him to stay home after vitals ok due to not wanting to expose the patient to actual Covid virus. At the time no fever 30 min after EMS left 104 fever sever chills, freezing coming in waves so weak. He can't get up to go to the bathroom. The reporter was worried and closely monitoring him. Treatment was received for the adverse event included Medication for vomiting, doctor apt in morning. The events were non-serious per the reporter. The patient underwent lab tests and procedures which included body temperature: no fever 25Mar2021, 104 30 min after EMS left on 25Mar2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: feeling unwell; sick to stomach; vomiting; chest pains; hard to breath; chills/freezing; weak; 104 fever; sore arm; sore muscles; This is a spontaneous report received from a contactable consumer (patient's mother). A 18-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 22Mar2021 14:00 (02:00 PM) (Lot Number: EP6955) at the age of 18 years old as single dose for covid-19 immunisation. Medical history included Known allergies Morphine and sulfa antibiotics; Marphans syndrome, autistic, severe scoliosis & kyphosis. The patient's concomitant medications received within 2 weeks of vaccination included too many to put down here not enuf room. Facility where the most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The mother took care of the patient due to his sever disability iam filling this out for his as he was unable so he received shot (pending clarification), registered with v-safe, 22Mar2021 2pm. Fine, health check next 23Mar2021 day sore arm, kinda sore muscles, 24Mar2021, sore arm still sore muscles, 25Mar2021 13:00 (1pm), feeling unwell, sick to stomach started vomiting, chest pains, hard to breath, called 911 EMS advised him to stay home after vitals ok due to not wanting to expose the patient to actual Covid virus. At the time no fever 30 min after EMS left 104 fever sever chills, freezing coming in waves so weak. He can't get up to go to the bathroom. The reporter was worried and closely monitoring him. Treatment was received for the adverse event included Medication for vomiting, doctor apt in morning. The events were non-serious per the reporter. The patient underwent lab tests and procedures which included body temperature: no fever 25Mar2021, 104 30 min after EMS left on 25Mar2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Fatigue, Orthostatic intolerance, Presyncope, Syncope
Clinical narrative: Set off extreme fatigue that led to syncope and near-syncope episodes; Set off extreme fatigue that led to syncope and near-syncope episodes; Increased orthostatic intolerance; Increased orthostatic intolerance; Set off extreme fatigue that led to syncope and near-syncope episodes; This is a spontaneous report received from contactable consumer (patient). A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: EB8727) via an unspecified route of administration in the right arm on 24Mar2021 11:30 AM (at the age of 21-year-old) as single dose for COVID-19 immunization in school or student health clinic. Medical history included ongoing POTS (Postural orthostatic tachycardia syndrome). Patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included corticosteroids, antihistamine and NSAID (all received within 2 weeks of vaccination). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205), via an unspecified route of administration in the left arm on 03Mar2021 10:00 AM for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 19:30 (reported as within 8hrs of vaccination), the patient experienced set off extreme fatigue that led to syncope and near-syncope episodes. Patient did not have an episode of POTS in months until receiving second dose, the patient experienced increased orthostatic intolerance. The patient did not receive any treatment for the events. The outcome of the events set off extreme fatigue that led to syncope and near-syncope episodes and increased orthostatic intolerance was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine; Contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine; This is a spontaneous case from a contactable consumer (patient's wife). This consumer reported similar events for five patients. This is the first of five reports.  A 49-year-old male patient (healthcare worker) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm, the first dose (Lot Number: EK5730) on 17Dec2020 at 11:00 AM and then the second dose (Lot Number: EL0142) on 07Jan2021 at 10:00, at a single dose, for COVID-19 immunization. The patient's medical history included ongoing attention deficit disorder (ADD; diagnosed probably about 19 years ago). The patient's concomitant medication included dextroamfetamine (DEXTROAMPHETAMINE) for ADD. The patient who was vaccinated with the Pfizer COVID-19 vaccine on 17Dec2020 and 07Jan2021 contracted COVID-19 on 26Feb2021 (a few weeks ago). The patient contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine. The patient developed symptoms of COVID-19 on 26Feb2021. The patient did not go to his physician but got checked for COVID-19 at work. The patient was tested for COVID-19 on 26Feb2021 and was made aware of the positive result on 28Feb2021. The patient's wife believed that the patient experienced symptoms of COVID-19 until 10Mar2021. The patient went back to work on 12Mar2021. The patient's wife has a friend that works for Pfizer whom she reported the patient's positive COVID-19 test post vaccination to. It was further reported that the patient works in a nursing home that is in a separate building but associated with a Medical Center. 16 people on the 5th floor of the Nursing Home tested positive for COVID-19 around the same time the patient received his positive test results. Of the 16 individuals that tested positive for COVID-19, four had been vaccinated, which is why the patient's wife is wondering if maybe there had been a bad batch of the product. Four people on the patient's floor at work tested positive for COVID-19 after receiving the COVID -19 vaccine. The patient recovered from the events on 10Mar2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331780 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331805 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331806 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331807 Same reporter and drug with lack of effect; different patient
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccination failure
Clinical narrative: Contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine; Contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine; This is a spontaneous case from a contactable consumer (patient's wife). This consumer reported similar events for five patients. This is the first of five reports.  A 49-year-old male patient (healthcare worker) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm, the first dose (Lot Number: EK5730) on 17Dec2020 at 11:00 AM and then the second dose (Lot Number: EL0142) on 07Jan2021 at 10:00, at a single dose, for COVID-19 immunization. The patient's medical history included ongoing attention deficit disorder (ADD; diagnosed probably about 19 years ago). The patient's concomitant medication included dextroamfetamine (DEXTROAMPHETAMINE) for ADD. The patient who was vaccinated with the Pfizer COVID-19 vaccine on 17Dec2020 and 07Jan2021 contracted COVID-19 on 26Feb2021 (a few weeks ago). The patient contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine. The patient developed symptoms of COVID-19 on 26Feb2021. The patient did not go to his physician but got checked for COVID-19 at work. The patient was tested for COVID-19 on 26Feb2021 and was made aware of the positive result on 28Feb2021. The patient's wife believed that the patient experienced symptoms of COVID-19 until 10Mar2021. The patient went back to work on 12Mar2021. The patient's wife has a friend that works for Pfizer whom she reported the patient's positive COVID-19 test post vaccination to. It was further reported that the patient works in a nursing home that is in a separate building but associated with a Medical Center. 16 people on the 5th floor of the Nursing Home tested positive for COVID-19 around the same time the patient received his positive test results. Of the 16 individuals that tested positive for COVID-19, four had been vaccinated, which is why the patient's wife is wondering if maybe there had been a bad batch of the product. Four people on the patient's floor at work tested positive for COVID-19 after receiving the COVID -19 vaccine. The patient recovered from the events on 10Mar2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331780 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331805 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331806 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331807 Same reporter and drug with lack of effect; different patient
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine; Contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine; This is a spontaneous case from a contactable consumer (patient's wife). This consumer reported similar events for five patients. This is the first of five reports.  A 49-year-old male patient (healthcare worker) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm, the first dose (Lot Number: EK5730) on 17Dec2020 at 11:00 AM and then the second dose (Lot Number: EL0142) on 07Jan2021 at 10:00, at a single dose, for COVID-19 immunization. The patient's medical history included ongoing attention deficit disorder (ADD; diagnosed probably about 19 years ago). The patient's concomitant medication included dextroamfetamine (DEXTROAMPHETAMINE) for ADD. The patient who was vaccinated with the Pfizer COVID-19 vaccine on 17Dec2020 and 07Jan2021 contracted COVID-19 on 26Feb2021 (a few weeks ago). The patient contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine. The patient developed symptoms of COVID-19 on 26Feb2021. The patient did not go to his physician but got checked for COVID-19 at work. The patient was tested for COVID-19 on 26Feb2021 and was made aware of the positive result on 28Feb2021. The patient's wife believed that the patient experienced symptoms of COVID-19 until 10Mar2021. The patient went back to work on 12Mar2021. The patient's wife has a friend that works for Pfizer whom she reported the patient's positive COVID-19 test post vaccination to. It was further reported that the patient works in a nursing home that is in a separate building but associated with a Medical Center. 16 people on the 5th floor of the Nursing Home tested positive for COVID-19 around the same time the patient received his positive test results. Of the 16 individuals that tested positive for COVID-19, four had been vaccinated, which is why the patient's wife is wondering if maybe there had been a bad batch of the product. Four people on the patient's floor at work tested positive for COVID-19 after receiving the COVID -19 vaccine. The patient recovered from the events on 10Mar2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331780 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331805 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331806 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331807 Same reporter and drug with lack of effect; different patient
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; contracted Covid-19; This is a spontaneous case from a contactable consumer (patient's wife). This consumer reported similar events for five patients. This is the second of five reports for first people. A 49-year-old male patient (healthcare worker, Husband) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm, the first dose (Lot Number: EK5730) on 17Dec2020 at 11:00 AM and then the second dose (Lot Number: EL0142) on 07Jan2021 at 10:00, at a single dose, for COVID-19 immunization. The patient's medical history included ongoing attention deficit disorder (ADD; diagnosed probably about 19 years ago). The patient family history not reported. The patient's concomitant medication included ongoing dextroamfetamine (DEXTROAMPHETAMINE) for ADD. The patient who was vaccinated with the Pfizer COVID-19 vaccine on 17Dec2020 and 07Jan2021 contracted COVID-19 on 26Feb2021 (a few weeks ago). The patient contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine. The patient developed symptoms of COVID-19 on 26Feb2021. The patient did not go to his physician but got checked for COVID-19 at work. The patient was tested for COVID-19 on 26Feb2021 and was made aware of the positive result on 28Feb2021. The patient's wife believed that the patient experienced symptoms of COVID-19 until 10Mar2021. The patient went back to work on 12Mar2021. The patient's wife has a friend that works for Pfizer whom she reported the patient's positive COVID-19 test post vaccination to. It was further reported that the patient works in a nursing home that is in a separate building but associated with a Medical Center. 16 people on the 5th floor of the Nursing Home tested positive for COVID-19 around the same time the patient received his positive test results. Of the 16 individuals that tested positive for COVID-19, four had been vaccinated, which is why the patient's wife is wondering if maybe there had been a bad batch of the product. Four people on the patient's floor at work tested positive for COVID-19 after receiving the COVID -19 vaccine. The patient recovered from the events on 10Mar2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 Same reporter, drug, and event; different patient;US-PFIZER INC-2021331715 Same reporter and drug with lack of effect; different patient
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccination failure
Clinical narrative: four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; contracted Covid-19; This is a spontaneous case from a contactable consumer (patient's wife). This consumer reported similar events for five patients. This is the second of five reports for first people. A 49-year-old male patient (healthcare worker, Husband) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm, the first dose (Lot Number: EK5730) on 17Dec2020 at 11:00 AM and then the second dose (Lot Number: EL0142) on 07Jan2021 at 10:00, at a single dose, for COVID-19 immunization. The patient's medical history included ongoing attention deficit disorder (ADD; diagnosed probably about 19 years ago). The patient family history not reported. The patient's concomitant medication included ongoing dextroamfetamine (DEXTROAMPHETAMINE) for ADD. The patient who was vaccinated with the Pfizer COVID-19 vaccine on 17Dec2020 and 07Jan2021 contracted COVID-19 on 26Feb2021 (a few weeks ago). The patient contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine. The patient developed symptoms of COVID-19 on 26Feb2021. The patient did not go to his physician but got checked for COVID-19 at work. The patient was tested for COVID-19 on 26Feb2021 and was made aware of the positive result on 28Feb2021. The patient's wife believed that the patient experienced symptoms of COVID-19 until 10Mar2021. The patient went back to work on 12Mar2021. The patient's wife has a friend that works for Pfizer whom she reported the patient's positive COVID-19 test post vaccination to. It was further reported that the patient works in a nursing home that is in a separate building but associated with a Medical Center. 16 people on the 5th floor of the Nursing Home tested positive for COVID-19 around the same time the patient received his positive test results. Of the 16 individuals that tested positive for COVID-19, four had been vaccinated, which is why the patient's wife is wondering if maybe there had been a bad batch of the product. Four people on the patient's floor at work tested positive for COVID-19 after receiving the COVID -19 vaccine. The patient recovered from the events on 10Mar2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 Same reporter, drug, and event; different patient;US-PFIZER INC-2021331715 Same reporter and drug with lack of effect; different patient
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; contracted Covid-19; This is a spontaneous case from a contactable consumer (patient's wife). This consumer reported similar events for five patients. This is the second of five reports for first people. A 49-year-old male patient (healthcare worker, Husband) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm, the first dose (Lot Number: EK5730) on 17Dec2020 at 11:00 AM and then the second dose (Lot Number: EL0142) on 07Jan2021 at 10:00, at a single dose, for COVID-19 immunization. The patient's medical history included ongoing attention deficit disorder (ADD; diagnosed probably about 19 years ago). The patient family history not reported. The patient's concomitant medication included ongoing dextroamfetamine (DEXTROAMPHETAMINE) for ADD. The patient who was vaccinated with the Pfizer COVID-19 vaccine on 17Dec2020 and 07Jan2021 contracted COVID-19 on 26Feb2021 (a few weeks ago). The patient contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine. The patient developed symptoms of COVID-19 on 26Feb2021. The patient did not go to his physician but got checked for COVID-19 at work. The patient was tested for COVID-19 on 26Feb2021 and was made aware of the positive result on 28Feb2021. The patient's wife believed that the patient experienced symptoms of COVID-19 until 10Mar2021. The patient went back to work on 12Mar2021. The patient's wife has a friend that works for Pfizer whom she reported the patient's positive COVID-19 test post vaccination to. It was further reported that the patient works in a nursing home that is in a separate building but associated with a Medical Center. 16 people on the 5th floor of the Nursing Home tested positive for COVID-19 around the same time the patient received his positive test results. Of the 16 individuals that tested positive for COVID-19, four had been vaccinated, which is why the patient's wife is wondering if maybe there had been a bad batch of the product. Four people on the patient's floor at work tested positive for COVID-19 after receiving the COVID -19 vaccine. The patient recovered from the events on 10Mar2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 Same reporter, drug, and event; different patient;US-PFIZER INC-2021331715 Same reporter and drug with lack of effect; different patient
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19; four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19; This is a spontaneous case from a contactable consumer. This consumer reported similar events for five patients. This is the third of five reports.  A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration, administered in the left arm on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that there had been four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19 on an unspecified date. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 same reporter and drug with lack of effect; different patient
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccination failure
Clinical narrative: four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19; four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19; This is a spontaneous case from a contactable consumer. This consumer reported similar events for five patients. This is the third of five reports.  A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration, administered in the left arm on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that there had been four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19 on an unspecified date. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 same reporter and drug with lack of effect; different patient
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19; four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19; This is a spontaneous case from a contactable consumer. This consumer reported similar events for five patients. This is the third of five reports.  A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration, administered in the left arm on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that there had been four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19 on an unspecified date. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 same reporter and drug with lack of effect; different patient
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported similar events for five patients. This is the third of five reports. A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that, there were four people who had been given the Pfizer COVID vaccines, that test positive for COVID 19 around the same time as that of reporter's husband, so the reporter is wondering if there was maybe a bad batch of the product that had been administered at the work. It was reported that they were tested positive for Covid-19 after receiving both doses of the Pfizer Covid-19 vaccine. Outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 Same reporter, drug, and event; different patient;US-PFIZER INC-2021331715 Same reporter and drug with lack of effect; different patient
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccination failure
Clinical narrative: four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported similar events for five patients. This is the third of five reports. A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that, there were four people who had been given the Pfizer COVID vaccines, that test positive for COVID 19 around the same time as that of reporter's husband, so the reporter is wondering if there was maybe a bad batch of the product that had been administered at the work. It was reported that they were tested positive for Covid-19 after receiving both doses of the Pfizer Covid-19 vaccine. Outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 Same reporter, drug, and event; different patient;US-PFIZER INC-2021331715 Same reporter and drug with lack of effect; different patient
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; four people on the patient's floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine.; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported similar events for five patients. This is the third of five reports. A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that, there were four people who had been given the Pfizer COVID vaccines, that test positive for COVID 19 around the same time as that of reporter's husband, so the reporter is wondering if there was maybe a bad batch of the product that had been administered at the work. It was reported that they were tested positive for Covid-19 after receiving both doses of the Pfizer Covid-19 vaccine. Outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 Same reporter, drug, and event; different patient;US-PFIZER INC-2021331715 Same reporter and drug with lack of effect; different patient
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Thrombosis
Clinical narrative: the problem was a bloodclot; slight swelling of right foot; This is a spontaneous report from a contactable consumer, the patient. A 72-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in the left arm on 09Mar2021 13:30 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure and allergy to tape. Concomitant medications included levothyroxine; olmesartan; metformin; all were taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine within four weeks prior to BNT162b2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Mar2021 15:00, the patient noticed slight swelling of right foot and on 14Mar2021, the swelling increased so the patient texted the nurse who arranged appointment. The nurse said to contact the doctor and the patient spoke with registered nurse (RN) on duty who told the patient to go to the emergency room (ER) because the symptoms indicated the problem was a blood clot. The ER doctor examined and ordered an ultrasound and the results confirmed blood clot. The patient was given a prescription for blood thinner to take for 21 days (times/day, 15mg) and was told to make an appointment with the primary doctor. The patient's doctor was on spring break and she was walked in to see another doctor who said swelling looked improved and showed her where the clots were located. The patient saw her primary doctor today and she ordered a visit with a hematologist as soon as possible (ASAP) because of concerns about possible underlying issues. The outcome of events, slight swelling of right foot and the problem was a blood clot was recovering.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: tested positive for covid; tested positive for covid; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a male patient of unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient has received vaccine Tuesday and will be receiving second dose but he tested positive for covid and wanted to know what to do. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Drug hypersensitivity, Sinus disorder
Clinical narrative: tested positive for covid; tested positive for covid; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a male patient of unspecified age received first dose of BNT162B2 (Pfizer Covid-19 Vaccine), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient has received vaccine Tuesday and will be receiving second dose but he tested positive for covid and wanted to know what to do. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccination failure
Clinical narrative: she has a friend that works for Pfizer that she reported the patient's positive Covid-19 test post vaccination to.; she reported the patient's positive Covid-19 test post vaccination to; This is a spontaneous report received from a contactable consumer (patient's friend). This consumer reported similar events for five patients. This is the one of five reports.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 07Jan2021 at 10:00 (Batch/Lot Number: EL0142) as single dose; dose 1 via an unspecified route of administration, administered in Arm Left on 17Dec2020 at 11:00 (Batch/Lot Number: EK5730) as single dose; both for covid-19 immunisation. Medical history included ongoing ADD (attention deficit hyperactivity disorder; diagnosed probably about 19 years ago). Concomitant medications included dextroamphetamine(DEXAMFETAMINE) taken for ADD (attention deficit hyperactivity disorder) from an unspecified start date and ongoing at 30mg twice a day. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's friend reported that she has a friend that works for Pfizer that she reported the patient tested positive for Covid-19 test post vaccination. The patient was tested for Covid-19 on 26Feb2021. The patient was made aware of the positive result on 28Feb2021 and developed symptoms of Covid-19 on 26Feb2021, and that the patient went back to work on 12Mar2021. The patient's friend stated that she believed the patient experienced symptoms of Covid-19 until 10Mar2021. The patient's friend reported that of the 16 individuals that tested positive for Covid-19, four had been vaccinated, which was why the caller was wondering if maybe there had been a bad batch of the product. The patient did not visit any emergency room and physician office. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 26Feb2021. The patient recovered from the events on 10Mar2021.  Additional information has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331780 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331805 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331806 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331807 Same reporter and drug with lack of effect; different patient
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: four people on the patient floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine; four people on the patient floor at work tested positive for Covid-19 after receiving the Covid-19 vaccine; This is a spontaneous case from a contactable consumer. This consumer reported similar events for four patients. This consumer reported for a patient (4th people) that: A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration, administered on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that there had been four people who had been given the Pfizer COVID vaccines and tested positive for COVID-19 on an unspecified date. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331131 Same reporter, drug, and event; different patient;US-PFIZER INC-2021331715 Same reporter and drug with lack of effect; different patient
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Oral pruritus, Pruritus, Rash, Wheezing
Clinical narrative: problem with her breathing; wheezing; itching in her mouth and all over; itching in her mouth and all over; fine rash on her upper body; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in arm on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included ongoing lupus erythematosus and ongoing sjogren's syndrome. Concomitant medications were not reported. The patient received her first dose of the Pfizer COVID-19 vaccine. She first had a problem with her breathing. Within a few minutes, she had itching in her mouth and all over. She had a fine rash on her upper body. She was itching and wheezing. She called to take her to the hospital. She was taken to the emergency room and administered 2 different intravenous medications. The doctor administered epinephrine injection. She was also given 50 mg oral diphenhydramine (BENADRYL). She was given an intravenous (IV) push of salmeterol, it's like famotidine (PEPCID). She clarified further it's like a form of prednisone. She also mentioned something else IV but did not know the name of it. The patient was also taking levosalbutamol hydrochloride (XOPENEX) as treatment. She was still having problems with itching. She was still really itchy. She asked when this stuff would clear out of her system. She had been taking diphenhydramine to calm down. She was constantly scratching. She took diphenhydramine and used her rescue inhaler. She had her inhaler, but she keeps itching. She carried an epinephrine (EPIPEN) and now she was having trouble with her breathing and she was trying to rest. Outcome of the rash and wheezing was unknown while of the remaining events was not recovered.  The following information on the batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness postural, Dyspnoea, Fatigue
Clinical narrative: I thought I was going to pass out.; Fatigue; congestion and runny nose; congestion and runny nose; arm pain; head and neck pain/head started throbbing/headache; head and neck pain; chills; I had a puffy face post-vaccine; I wasn't feeling well; I had difficulty breathing; I felt dizzy when bending over and standing up; My heart rate also increased to 100-120 bpm; Arm injection site is very itchy; Arm injection site is very itchy, and now around 2 inches in size; Arm injection site swelling; Arm injection site swelling and redness; muscle aches; Fever maximum 100.5F; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration  in the arm on an unspecified date (Lot Number: EL3247; Expiration Date: May2021) as SINGLE DOSE for COVI-19 immunization. Medical history included allergy/contact dermatitis from latex, allergy/sensitivity to dairy, eczema in teens and IBS in 2018. The patient's concomitant medications were not reported. The patient previously took steroids and experienced allergies to steroids. The patient previously had first dose of BNT162B2 on unspecified date for COVID-19 immunisation and experienced site injection and shoulder pain in left arm, left hand pinky finger and ring finger tingling and ache and pain all day in left hand. The patient experienced fatigue, congestion and runny nose, arm pain, head and neck pain and chills on unspecified date. On 24Mar2021, the patient had arm injection site swelling and redness, headache, muscle aches, severe chills and fever maximum 100.5F and kept stable with Tylenol taken every 6 hours. The patient had a puffy face post-vaccine. This started 3 hours after vaccination dose 2, and resolved by evening of 24Mar2021. The patient wasn't feeling well on unspecified date. On 25Mar2021, the patient was still severely fatigued. The patient went downstairs to get takeout/delivery, and after coming up half a flight of stairs which would consider as minor exertion by the patient. The patient had difficulty breathing, stated, "my head started throbbing, and I thought I was going to pass out. This happened again when I was trying to load/unload the dishwasher and I felt dizzy when bending over and standing up. I developed a headache for around 1 hour. My heart rate also increased to 100-120 bpm." The patient had arm injection site was very itchy, and now around 2 inches in size. The events took place after use of product. Therapeutic measures were taken as a result of , arm injection site swelling and redness, muscle aches and fever maximum 100.5f. The outcome of the event fatigue was not recovered. The outcome of the event puffy face was recovered on 24Mar2021. The outcome of the rest of the events was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Malaise, Myalgia
Clinical narrative: I thought I was going to pass out.; Fatigue; congestion and runny nose; congestion and runny nose; arm pain; head and neck pain/head started throbbing/headache; head and neck pain; chills; I had a puffy face post-vaccine; I wasn't feeling well; I had difficulty breathing; I felt dizzy when bending over and standing up; My heart rate also increased to 100-120 bpm; Arm injection site is very itchy; Arm injection site is very itchy, and now around 2 inches in size; Arm injection site swelling; Arm injection site swelling and redness; muscle aches; Fever maximum 100.5F; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration  in the arm on an unspecified date (Lot Number: EL3247; Expiration Date: May2021) as SINGLE DOSE for COVI-19 immunization. Medical history included allergy/contact dermatitis from latex, allergy/sensitivity to dairy, eczema in teens and IBS in 2018. The patient's concomitant medications were not reported. The patient previously took steroids and experienced allergies to steroids. The patient previously had first dose of BNT162B2 on unspecified date for COVID-19 immunisation and experienced site injection and shoulder pain in left arm, left hand pinky finger and ring finger tingling and ache and pain all day in left hand. The patient experienced fatigue, congestion and runny nose, arm pain, head and neck pain and chills on unspecified date. On 24Mar2021, the patient had arm injection site swelling and redness, headache, muscle aches, severe chills and fever maximum 100.5F and kept stable with Tylenol taken every 6 hours. The patient had a puffy face post-vaccine. This started 3 hours after vaccination dose 2, and resolved by evening of 24Mar2021. The patient wasn't feeling well on unspecified date. On 25Mar2021, the patient was still severely fatigued. The patient went downstairs to get takeout/delivery, and after coming up half a flight of stairs which would consider as minor exertion by the patient. The patient had difficulty breathing, stated, "my head started throbbing, and I thought I was going to pass out. This happened again when I was trying to load/unload the dishwasher and I felt dizzy when bending over and standing up. I developed a headache for around 1 hour. My heart rate also increased to 100-120 bpm." The patient had arm injection site was very itchy, and now around 2 inches in size. The events took place after use of product. Therapeutic measures were taken as a result of , arm injection site swelling and redness, muscle aches and fever maximum 100.5f. The outcome of the event fatigue was not recovered. The outcome of the event puffy face was recovered on 24Mar2021. The outcome of the rest of the events was unknown.